Advertisement
GEHC vs PHG
Which Stock Would AI Choose? GE HealthCare Technologies (GEHC) vs. Koninklijke Philips (PHG) Stock Comparison
Key Takeaways
- GEHC delivered stronger year-to-date gains at around 25%, outperforming PHG's negative return of about 3%.
- Recent market activity saw GEHC decline sharply after Q1 results with revenue beats but earnings misses and guidance cuts, while PHG experienced milder pullbacks.
- GEHC trades at a lower trailing P/E ratio of 14.6 compared to PHG's 24.0, suggesting relatively cheaper valuation.
- Both firms operate in medical technology, but GEHC emphasizes AI and diagnostics, while PHG spans diagnosis, treatment, and connected care.
- Market caps are comparable, with GEHC at $27.8B and PHG at $25B, reflecting similar scale in the healthcare equipment sector.
Introduction
This stock comparison examines GEHC and PHG, two prominent players in the medical technology sector focused on diagnostics, imaging, and patient care solutions. Investors tracking healthcare equipment stocks may find value in analyzing their relative performance amid evolving market conditions, supply chain pressures, and innovation in AI-driven health tech. Traders seeking exposure to growth drivers like digital infrastructure and therapeutic devices can assess momentum, valuations, and sentiment shifts to inform position sizing in portfolios emphasizing relative performance and market positioning.
GEHC Overview and Recent Performance
GEHC, or GE HealthCare Technologies Inc., is a leading provider of advanced medical technologies, pharmaceutical diagnostics, and digital solutions including AI and cloud-based tools for patient diagnosis and monitoring. Spun off from General Electric in 2023, the company operates in imaging, ultrasound, and patient care segments. In recent market activity, shares have faced downward pressure, declining over 12% in the past week and 14% monthly following first-quarter results that showed revenue of $5.13 billion exceeding estimates but earnings per share missing due to rising costs and a supplier issue. Profit guidance was trimmed, influencing negative sentiment despite year-to-date gains near 25% and a current price around $61, with a 52-week range of $59-$90. Analyst targets average $80, reflecting optimism in long-term catalysts like product innovations.
PHG Overview and Recent Performance
PHG, Koninklijke Philips N.V., is a Dutch health technology firm with segments in diagnosis and treatment, connected care, and personal health products. It delivers integrated solutions for imaging, monitoring, and informatics to enhance clinical workflows. Recent weeks have seen modest declines, with shares down about 4% monthly and 3% year-to-date, trading near $26 amid broader sector rotation. A recent dividend announcement of $1.01 provided some support, but performance lags peers due to ongoing supply challenges and softer demand in certain regions. Valuation metrics include a trailing P/E of 24 and forward P/E of 14, with a market cap of $25 billion. Profit margins stand at 5%, with quarterly revenue growth of 1.1% year-over-year, underscoring steady but cautious momentum.
Trending AI Robots
Tickeron's Trending AI Robots page curates the top 25 performers from over 350 AI trading bots that analyze thousands of tickers across diverse strategies, timeframes, and market conditions. These bots employ AI/ML for real-time signals, featuring win rates from 51% to 88%, annualized returns ranging 24% to 163%, profit factors of 1.5 to 11.7, and profit-to-drawdown ratios up to 17. Examples include semiconductor-focused bots with 83-97% annualized gains and volatility agents yielding up to 163%. Suited for current trends in AI infrastructure, industrials, and small caps, they offer swing trading, corridor exits (e.g., 3% take-profit/2% stop-loss), and multi-agent approaches. Explore these high-performing options to align with dynamic market environments.
Head-to-Head Comparison
Both GEHC and PHG compete in healthcare equipment, but GEHC leans toward precision diagnostics and AI integration, driving growth via digital platforms, while PHG emphasizes end-to-end care with broader exposure to monitoring and personal health devices. Recent momentum favors neither decisively, as GEHC's earnings volatility contrasts PHG's steadier declines. Valuation trade-offs highlight GEHC's attractive trailing P/E versus PHG's forward discount. Risk factors include supply disruptions for both, though PHG carries higher debt/equity at 74%. Sector exposure aligns on medtech, but sentiment tilts toward GEHC for innovation catalysts amid relative underperformance risks for PHG.
Tickeron AI Verdict
Tickeron's AI models currently lean toward GEHC with moderate confidence, citing superior year-to-date performance, revenue resilience, and lower valuation multiples positioning it better for potential rebound in AI health tech trends. PHG offers stability via dividends and forward P/E appeal but trails in momentum and growth consistency.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEHC is a StrongBuy and PHG is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GEHC’s FA Score shows that 0 FA rating(s) are green whilePHG’s FA Score has 1 green FA rating(s).
- GEHC’s FA Score: 0 green, 5 red.
- PHG’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GEHC’s TA Score shows that 4 TA indicator(s) are bullish while PHG’s TA Score has 4 bullish TA indicator(s).
- GEHC’s TA Score: 4 bullish, 5 bearish.
- PHG’s TA Score: 4 bullish, 5 bearish.
Price Growth
GEHC (@Medical/Nursing Services) experienced а +1.15% price change this week, while PHG (@Medical/Nursing Services) price change was +1.87% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.53%. For the same industry, the average monthly price growth was -0.09%, and the average quarterly price growth was -5.17%.
Reported Earning Dates
PHG is expected to report earnings on Jul 28, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.53% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| GEHC | PHG | GEHC / PHG | |
| Capitalization | 28.1B | 25.9B | 108% |
| EBITDA | 3.6B | 2.68B | 135% |
| Gain YTD | -24.708 | -1.292 | 1,912% |
| P/E Ratio | 14.80 | 22.68 | 65% |
| Revenue | 21B | 17.6B | 119% |
| Total Cash | 2.26B | 2.59B | 87% |
| Total Debt | 10.6B | 8.1B | 131% |
PHG | ||
|---|---|---|
OUTLOOK RATING 1..100 | 8 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 76 | |
PRICE GROWTH RATING 1..100 | 59 | |
P/E GROWTH RATING 1..100 | 99 | |
SEASONALITY SCORE 1..100 | 26 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| GEHC | PHG | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 76% | 2 days ago 71% |
| Stochastic ODDS (%) | 2 days ago 70% | 2 days ago 63% |
| Momentum ODDS (%) | 2 days ago 56% | 2 days ago 64% |
| MACD ODDS (%) | 2 days ago 61% | 2 days ago 64% |
| TrendWeek ODDS (%) | 2 days ago 68% | 2 days ago 59% |
| TrendMonth ODDS (%) | 2 days ago 63% | 2 days ago 60% |
| Advances ODDS (%) | 7 days ago 70% | 7 days ago 62% |
| Declines ODDS (%) | 14 days ago 59% | 14 days ago 64% |
| BollingerBands ODDS (%) | 2 days ago 65% | 2 days ago 77% |
| Aroon ODDS (%) | 2 days ago 50% | 2 days ago 60% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EGGY | 40.31 | 1.90 | +4.95% |
| NestYield Dynamic Income ETF | |||
| PRN | 245.38 | 5.83 | +2.43% |
| Invesco Dorsey Wright IndustrialsMomtETF | |||
| SGLC | 42.92 | 0.16 | +0.37% |
| SGI U.S. Large Cap Core ETF | |||
| CPSA | 27.53 | 0.03 | +0.11% |
| Calamos S&P 500 Str Alt Prt ETF-Aug | |||
| UCON | 24.94 | -0.04 | -0.16% |
| First Trust Smith Unconstrained Pl BdETF | |||
GEHC and
Correlation & Price change
A.I.dvisor indicates that over the last year, GEHC has been loosely correlated with CPAY. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if GEHC jumps, then CPAY could also see price increases.
| Ticker / NAME | Correlation To GEHC | 1D Price Change % | ||
|---|---|---|---|---|
| GEHC | 100% | -2.79% | ||
| CPAY - GEHC | 60% Loosely correlated | -0.70% | ||
| EEFT - GEHC | 57% Loosely correlated | +1.12% | ||
| GEN - GEHC | 56% Loosely correlated | -1.23% | ||
| ROP - GEHC | 54% Loosely correlated | -4.23% | ||
| ALIT - GEHC | 53% Loosely correlated | -11.47% | ||
More | ||||
PHG and
Correlation & Price change
A.I.dvisor indicates that over the last year, PHG has been loosely correlated with RYLPF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then RYLPF could also see price increases.
| Ticker / NAME | Correlation To PHG | 1D Price Change % | ||
|---|---|---|---|---|
| PHG | 100% | -1.76% | ||
| RYLPF - PHG | 56% Loosely correlated | N/A | ||
| GEHC - PHG | 53% Loosely correlated | -2.79% | ||
| ALC - PHG | 49% Loosely correlated | -0.86% | ||
| CNMD - PHG | 46% Loosely correlated | -4.16% | ||
| ENOV - PHG | 43% Loosely correlated | -6.56% | ||
More | ||||